High expression of kinesin light chain-2, a novel target of miR-125b, is associated with poor clinical outcome of elderly non-small-cell lung cancer patients.

Notably, high KLC2 expression appeared to be associated with shorter overall survival in male patients, or in patients either with squamous cell carcinoma, or with N0 disease, or with Stage I/II disease, although the correlation did not reach statistical significance ( Supplementary Figure 3 ).

also in 111,027 other papers